title: Human herpesvirus 6 encephalitis following flag chemotherapy.
authors.forename: Annette L
authors.initials: AL
authors.lastname: Nicolle
authors.forename: Gail L
authors.initials: GL
authors.lastname: Stark
authors.forename: Clive E
authors.initials: CE
authors.lastname: Taylor
authors.forename: Wendy
authors.initials: W
authors.lastname: Wipat
authors.forename: Graham H
authors.initials: GH
authors.lastname: Jackson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects*; D018792:Encephalitis, Viral / Q000276:immunology*; D017809:Fatal Outcome; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D015654:Herpesvirus 6, Human; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000276:immunology; D019349:Roseolovirus Infections / Q000276:immunology*; D014740:Vidarabine / Q000009:adverse effects* / Q000031:analogs & derivatives
chemical_list: D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D014740:Vidarabine